InvestSMART

Radiopharm Theranostics Limited (ASX: RAD) - Announcements

Current share price for RAD : $0.007 0.001 (12.50%)+

ASX company news and announcements for Radiopharm Theranostics Limited (RAD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Radiopharm Theranostics Limited (RAD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Radiopharm Theranostics Limited (RAD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Radiopharm Theranostics Limited (RAD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$33 Change of Director's Interest Notices x 4 22 Sep 2026 2:13PM $0.008 $0.007 fallen by 12.50%
$33 Notification regarding unquoted securities - RAD 17 Sep 2026 10:47AM $0.008 $0.007 fallen by 6.67%
$33 RADOC New Class Options Range of Units and Top 20 Holders 17 Sep 2026 10:41AM $0.008 $0.007 fallen by 6.67%
$33 Application for quotation of securities - RAD 17 Sep 2026 10:37AM $0.008 $0.007 fallen by 6.67%
$33 Application for quotation of securities - RAD 17 Sep 2026 10:30AM $0.008 $0.007 fallen by 6.67%
$33 Share purchase plan completed 17 Sep 2026 10:11AM $0.008 $0.007 fallen by 6.67%
$33 RAD oral presentation at SNO26 on RAD101 Phase IIb data 14 Sep 2026 8:54AM $0.008 $0.007 fallen by 12.50%
$33 Results of Meeting 11 Sep 2026 12:35PM $0.009 $0.007 fallen by 22.22%
$33 RAD Announces Positive Data from RAD301 P1 Imaging Trial 9 Sep 2026 9:21AM $0.009 $0.007 fallen by 22.22%
$33 Appendix 4E and Preliminary Final Report 28 Aug 2026 4:07PM $0.009 $0.007 fallen by 22.22%
$33 Change of Director's Interest Notices x 4 27 Aug 2026 2:50PM $0.010 $0.007 fallen by 30%
$33 RAD Doses First Patient in Second Cohort of BetaBart (RV-01) 26 Aug 2026 8:59AM $0.011 $0.007 fallen by 33.33%
$33 Ceasing to be a substantial holder 24 Aug 2026 4:43PM $0.011 $0.007 fallen by 36.36%
$33 RAD advances to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Trial 20 Aug 2026 8:51AM $0.012 $0.007 fallen by 41.67%
$33 Change in substantial holding 17 Aug 2026 4:52PM $0.011 $0.007 fallen by 36.36%
$33 RAD to meet with US FDA to align on RAD 101 Phase 3 Trial 17 Aug 2026 9:02AM $0.011 $0.007 fallen by 36.36%
$33 Notice of Extraordinary General Meeting and Proxy Form 13 Aug 2026 8:22AM $0.012 $0.007 fallen by 41.67%
$33 Share Purchase Plan - Now Open 7 Aug 2026 9:38AM $0.013 $0.007 fallen by 46.15%
$33 Update - Proposed issue of securities - RAD 5 Aug 2026 1:56PM $0.013 $0.007 fallen by 46.15%
$33 Application for quotation of securities - RAD 3 Aug 2026 10:51AM $0.013 $0.007 fallen by 44%
$33 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2026 11:19AM $0.013 $0.007 fallen by 46.15%
$33 Change in substantial holding 30 Jul 2026 4:48PM $0.014 $0.007 fallen by 50%
$33 Target market determination (TMD) 30 Jul 2026 4:32PM $0.014 $0.007 fallen by 50%
$33 Prospectus 30 Jul 2026 4:25PM $0.014 $0.007 fallen by 50%
$33 Notice Under Section 708A 28 Jul 2026 4:19PM $0.015 $0.007 fallen by 53.33%

1 - 25 of 626 results

Page 1 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.